Effectiveness of Canakinumab for First‐Line Steroid‐Free Treatment in Systemic‐Onset Juvenile Idiopathic Arthritis and Juvenile Still Disease

Objective This prospective study assesses the response to canakinumab monotherapy administered as three monthly subcutaneous injections in glucocorticoid‐naïve patients with newly diagnosed systemic juvenile idiopathic arthritis (sJIA) and Still disease and evaluates the durability of drug‐free inac...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Gerd Horneff, Tilman Kallinich, Markus Hufnagel, Kirsten Minden, Frank Weller‐Heinemann, Ralf Trauzeddel, Dirk Foell, Claas Hinze, Fabienne Staubi, Ariane Klein
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2026-04-01
coleção:	ACR Open Rheumatology
Acesso em linha:	https://doi.org/10.1002/acr2.90028
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!